Biotechnology - Burlingame, California, United States
Neugenesis Corporation is focused on generating better biotherapeutics, cost-effectively. To this end, Neugenesis has developed technology that has substantial value in the discovery, improvement and production of complex proteins; especially heteromeric proteins. The Company's work with the filamentous fungi Neurospora crassa has resulted in significant advances in three important areas of biotechnology: directed evolution, combinatorial biology and recombinant protein expression. Neugenesis was acquired by Intrexon Corporation in April, 2011.
Google AdSense
Google Cloud Hosting
Mobile Friendly